Organic Active Ingredients TRIZ Cases

Indole and indazole derivatives prevent reperfusion injury during organ preservation, extending viability windows.

Topical tenofovir gel reduces herpes simplex virus transmission risk by fifty-one percent via localized antiviral activity.

Intranasal sumatriptan free base with alkyl glycosides reduces rescue medication need by 50% and prevents medication overuse headache.

Segmenting collagen and dextran layers resolves the trade-off between immediate barrier function and sustained drug release, preventing adhesion formation.

Form-M3 ensures long-term physical stability for hepatitis C treatments by resolving synthesis contradictions via parameter changes.

Supercritical CO2 extraction and chromatography isolate minor cannabinoids and terpenes to enhance bioavailability while maintaining legal THC limits.

Formulas I and II compounds inhibit Naegleria fowleri, reducing mortality and safety concerns.

Rinsing shredded hemp removes heavy metals and chlorophyll, eliminating lung irritation risks while preserving airflow channels in the smoking mixture.

Antisense oligonucleotides target tau mRNA to decrease protein levels via steric blocking and RNase H activation.

Injectable neurosteroid formulations overcome allopregnanolone's short half-life by using cyclodextrin inclusion complexes and nanoparticle stabilizers.

2',4'-Bridged nucleosides target RNA-dependent RNA polymerase viruses, reducing toxicity while maintaining treatment effectiveness.

C1-4 alkyl glycosides selectively stimulate beneficial oral bacteria growth, suppressing pathogenic strains without broad-spectrum antibacterial resistance.

Deferiprone targets mitochondrial iron stores to minimize oxidative damage while avoiding generalized toxicity in Friedreich ataxia treatment.

Segmented pyrrolidine derivatives inhibit TGFbeta activation by selectively blocking alpha v beta 6 integrin, addressing limited pulmonary fibrosis therapies.

Substituted fused bicyclic imidazole derivatives resolve specificity challenges by acting as potent modulators of human IL-17 activity.

Amino-quinoline peripheral site ligands boost reactivation efficiency against tabun-inhibited enzymes while reducing side effects through optimized binding.

Cerium oxide nanoparticles target tumors with radiation and chemotherapy, reducing normal tissue toxicity.

An oil-based formulation eliminates extruders and curing times by pouring a heated mixture that solidifies upon cooling.

A stable nanocomplex uses anionic lipids and polyanionic polymers to bind proteins without covalent modification.

Microcrystalline suspensions with co-polymer surfactants extend synovial residence half-life, reducing injection frequency for chronic arthritis.

Optimized fucoidan molecular weight enhances chondrogenesis without side effects, resolving trade-offs in therapeutic reliability.

Oral epsilon aminocaproic acid prevents thrombocytopenic bleeds by inhibiting fibrinolysis, avoiding alloimmunization from platelet transfusions.

Merges xenobiotic metabolism activators with chelators to extend lifespan by enhancing detoxification while addressing complex aging etiology.

Inhibiting DNMT3A and EZH2 repressors upregulates the FXN gene, addressing ineffective therapies that fail to restore frataxin levels in Friedreich ataxia.

A carboxymethylcellulose and pectin matrix protects Megasphaera elsdenii from acidic rumen conditions, enhancing bacterial viability during storage.

Polyferric sulfate injection eliminates hemorrhoids and tumors by dehydrating tissue, avoiding invasive surgical procedures.

A pharmaceutical composition of chlorogenic acid and coumaroylquinic acid reverses tumor multi-drug resistance through synergistic action.

A dissolvable polymeric ocular insert releases olopatadine and mucoadhesive polymers to extend drug residence time on the cornea.

Benzodiazepine compounds target VEGF-induced vascular leakage by inhibiting calcium elevation, preventing retinopathy complications.

Tape preparation delivers WT1 peptide via adhesive layer to induce cellular immunity without injection pain or medical waste.

A cochlear lead applies a lubricant coating and releases dexamethasone base to prevent tissue trauma and inflammation during implantation.

Low-dose PARP inhibitor partially reduces enzymatic activity to modulate the tumor microenvironment.

Combining IN10018 with pegylated liposomal doxorubicin treats ovarian cancer through synergistic multi-pathway inhibition.

Phosphate esterification modifies cannabinoid molecules to improve water solubility, overcoming low oral bioavailability and rapid tissue redistribution.

Replacing immunogenic CTGF with small molecules Oxo-M and 4-PPBP activates FAK/ERK signaling for cost-effective tendon regeneration.

Inhibiting ERp57 and GSTP proteins disrupts apoptosis signaling pathways to treat oxidative stress conditions.

Topical phospholipid vesicles replace invasive injections by penetrating skin to replenish synovial fluid and reduce pain.

Wnt ligand proteins suppress HIV replication via transcriptional targeting, avoiding side effects and resistance from enzyme inhibitors.

Co-administering low-concentration fluoxetine and vitamin C inhibits MMP-9 activation and restores memory in ischemia models while reducing side effects.

Tricyclic compounds selectively inhibit PDE4A and PDE4B isoforms, reducing gastrointestinal side effects from PDE4D inhibition.

Segmented polymers with hydrophobic portions maintain adhesion strength and water resistance during transdermal drug delivery.

Small molecule SRPK1 inhibitors enable non-invasive topical treatment of ocular neovascularization by replacing frequent intraocular injections.

Eltoprazine treats cognitive impairments while reducing side effects and abuse potential.

ActRIIB antagonists inhibit signaling pathways to regenerate thermogenic adipocytes, addressing the lack of effective methods for inducing brown fat in adults.

Acetonitrile and dimethyl sulfoxide solvents convert gelatinous intermediates into filterable crystals, improving yield and purity.

LSD1 inhibition increases double-stranded RNA stress, activating the cGAS-STING pathway to overcome limited T cell infiltration in refractory tumors.

Surfactant additives prevent active ingredient segregation in TG 227 ea and TG 134 a propellant systems, ensuring stable suspension homogeneity.